Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration

被引:419
作者
Tsai, Yin-Meng [1 ]
Chien, Chao-Feng [1 ]
Lin, Lie-Chwen [1 ,2 ]
Tsai, Tung-Hu [1 ,3 ]
机构
[1] Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei 112, Taiwan
[2] Natl Res Inst Chinese Med, Taipei, Taiwan
[3] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan
关键词
Curcumin; PLGA; Nanoparticles; Blood-brain barrier; Pharmacokinetics; IN-VIVO; PARKINSONS-DISEASE; NANOPARTICLES; PHARMACOKINETICS; RELEASE; RATS; BIOAVAILABILITY; MODEL; MICROSPHERES; INFLAMMATION;
D O I
10.1016/j.ijpharm.2011.06.030
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Curcumin has considerable neuro-protective and anti-cancer properties but is rapidly eliminated from the body. By optimizing the HPLC method for analysis of curcumin, this study evaluates how the ability of curcumin to penetrate organs and different regions of the brain is affected by nanoparticulation to increase curcumin circulation time in the body. Curcumin-loaded PLGA nanoparticles (C-NPs) were prepared by the high-pressure emulsification-solvent evaporation method. The mean particle size and entrapment efficiency were 163 nm and 46.9%, respectively. The release profile of C-NPs was an initial burst effect followed by sustained diffusion. In distribution studies, curcumin could be detected in the evaluated organs, including liver, heart, spleen, lung, kidney and brain. C-NPs were found mainly in the spleen, followed by the lung. Formulation significantly raised the curcumin concentration in these organs with increases in the AUC, t(1/2) and MRT of curcumin, though this was not apparent in the heart. Curcumin and C-NPs could cross the blood-brain barrier (BBB) to enter brain tissue, where it was concentrated chiefly in the hippocampus. Nanoparticulation significantly prolonged retention time of curcumin in the cerebral cortex (increased by 96%) and hippocampus (increased by 83%). These findings provide further understanding for the possible therapeutic effects of curcumin and C-NPs in further pre-clinical and clinical research. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 43 条
[1]
Freeze-drying of nanoparticles: Formulation, process and storage considerations [J].
Abdelwahed, Wassim ;
Degobert, Ghania ;
Stainmesse, Serge ;
Fessi, Hatem .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1688-1713
[2]
Strategy for effective brain drug delivery [J].
Alam, M. Intakhab ;
Beg, Sarwar ;
Samad, Abdus ;
Baboota, Sanjula ;
Kohli, Kanchan ;
Ali, Javed ;
Ahuja, Alka ;
Akbar, M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (05) :385-403
[3]
PHARMACOLOGY OF CURCUMA-LONGA [J].
AMMON, HPT ;
WAHL, MA .
PLANTA MEDICA, 1991, 57 (01) :1-7
[4]
Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[5]
RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo (Retracted article. See vol. 102, pg. 143, 2016) [J].
Anand, Preetha ;
Nair, Hareesh B. ;
Sung, Bokyung ;
Kunnumakkara, Ajaikumar B. ;
Yadav, Vivek R. ;
Tekmal, Rajeshwar R. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (03) :330-338
[6]
Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain [J].
Andrade, Danielle M. .
HUMAN GENETICS, 2009, 126 (01) :173-193
[7]
Herb-drug interaction of Andrographis paniculata extract and andrographolide on the pharmacokinetics of theophylline in rats [J].
Chien, Chao-Feng ;
Wu, Yu-Tse ;
Lee, Wen-Chuan ;
Lin, Lie-Chwen ;
Tsai, Tung-Hu .
CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 184 (03) :458-465
[8]
Review of the oral toxicity of polyvinyl alcohol (PVA) [J].
DeMerlis, CC ;
Schoneker, DR .
FOOD AND CHEMICAL TOXICOLOGY, 2003, 41 (03) :319-326
[9]
PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release [J].
Faisant, N ;
Siepmann, J ;
Benoit, JP .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 15 (04) :355-366
[10]
Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model [J].
Garcia-Alloza, M. ;
Borrelli, L. A. ;
Rozkalne, A. ;
Hyman, B. T. ;
Bacskai, B. J. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (04) :1095-1104